Eblasakimab Improves Multiple Disease Measures in Adult Patients with Moderate-to-severe Atopic Dermatitis in a Randomized, Double-blinded, Placebo-controlled, Phase 1 Study

Karen A. Veverka, Ferda Cevikbas, Steven Tien Guan Thng,Melinda Gooderham, Eric Simpson

25th World Congress of Dermatology, July 2023